Last updated: 11/07/2018 17:26:51
A Multicenter, Open-Label, Pilot study of Lamotrigine as Adjunctive Therapy and Monotherapy in Patients with Epilepsy and Comorbid Depressive Symptoms
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Multicenter, Open-Label, Pilot study of Lamotrigine as Adjunctive Therapy and Monotherapy in Patients with Epilepsy and Comorbid Depressive Symptoms
Trial description: A Multicenter, Open-Label, Pilot study of Lamotrigine as Adjunctive Therapy and Monotherapy in Patients with Epilepsy and Comorbid Depressive Symptoms
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: an evaluation of lamotrigine on mood in older adults with epilepsy and comorbid depressive symptoms. Fakhoury, Toufic A MD 1, Miller, James M PharmD 2, Hammer, Anne E BS 3, and Vuong, Alain BS 2 59th Annual Meeting of the American Epilepsy Society held jointly with the American Clinical Neurophysiology Society 12/2/2005 Washington, DC; USA
Abstract: lamotrigine in patients with epilepsy and comorbid depressive symptoms. Fakhoury, Toufic A. 1, Barry, John J. 2, Miller, James M. 3, Hammer, Anne E. 3, and Vuong, Alain 3 57th Annual Meeting of the American Academy of Neurology 4/9/2005 Miami Beach, FL; USA
Abstract: lamotrigine in patients with epilepsy and comorbid depressive symptoms. Fakhoury, Toufic M. D. 1, Barry, John J. M. D. 2, Miller, James M. Pharm. D. 3, Hammer, Anne E. B. S. 3, and Vuong, Alain B. S. 3 45th Annual Meeting of the New Clinical Drug Evaluation Unit (NCDEU) 6/6/2005 Boca Raton, FL; USA
Abstract: lamotrigine in patients with epilepsy and comorbid depressive symptoms: preliminary report. FAKHOURY, Toufic A. MD, BARRY, John J. MD, MILLER, James M. PharmD, and HAMMER, Anne E. BS 58th Annual Meeting of the American Epilepsy Society 12/3/2004 New Orleans, LA; USA
Medical condition
Epilepsy
Product
lamotrigine
Collaborators
Not applicable
Study date(s)
October 2002 to May 2004
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2004-17-05
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website